|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01226589 |
|
Date of registration:
|
21/10/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Pharmacist Discharge Medication Reconciliation Study
|
|
Scientific title:
|
The Impact of Pharmacist Discharge Medication Reconciliation on Unintentional Medication Discrepancies From Inpatient Discharges at the Alberta Cancer Board Cross Cancer Institute |
|
Date of first enrolment:
|
October 2007 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01226589 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Carole Chambers, BSc. Pharmacy |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Alberta Health Services |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Cancer inpatients under the care of Dr. Follett or Dr. Candler
- Cancer inpatients to be discharged from the CCI
- Patients >18 years of age
- Patients that are taking >1 medications or herbals total at home.
Exclusion Criteria:
- Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron
patients or patients receiving radiation treatment for thyroid)
- Patients that do not remain in hospital >72 hours
- Patients without a home phone number or equivalent contact number.
- Language barrier (patients unable to speak or understand English).
- Patients that are readmitted and already included into the study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Medication Reconciliation
|
|
Intervention(s)
|
|
Procedure: MRS
|
|
Primary Outcome(s)
|
|
MRS Correlation with Treatment Response.
[Time Frame: up to 1 year]
|
|
Secondary Outcome(s)
|
|
Correlation with Tumor Stage
[Time Frame: up to 1 year]
|
|
The frequency of each type of unintentional medication discrepancies.
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|